 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial primary completion date, Head-to-Head: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis (clinicaltrials.gov) - Nov 9, 2023
P2b, N=140, Recruiting, Sponsor: Nature Cell Co. Ltd.
Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Jun 2023 --> Jun 2024
- XT-150 / Xalud Therap
Lack of Systemic Effects from Intra-articular XT-150 for the Treatment of Moderate to Severe Pain Due to OA of the Knee: Safety Results from a Phase 2 Trial (Poster Hall; in person) - Sep 23, 2023 - Abstract #ACRConvergence2023ACR_Convergence_2429;
P2
The local nature of treatment-related AEs and the absence of treatment-related SAEs support a two-dose regimen of 0.45 mg XT-150 (total dose of 0.9 mg) as safe and well-tolerated for future studies. 1.
- XT-150 / Xalud Therap
Efficacy of XT-150, a Novel Non-Viral Gene Therapy Delivering IL-10v, on Moderate to Severe Pain Due to Osteoarthritis of the Knee: Results of a Phase 2 Trial (Room 6F/6C; in person) - Sep 23, 2023 - Abstract #ACRConvergence2023ACR_Convergence_1693;
P2
1. Kwilasz AJ, et al.
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial primary completion date: Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy (clinicaltrials.gov) - Sep 28, 2022
P=N/A, N=14, Not yet recruiting, Sponsor: R-Bio
Kwilasz AJ, et al. Trial completion date: Dec 2028 --> Dec 2029 | Trial primary completion date: Dec 2027 --> Dec 2028
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial primary completion date: Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration (clinicaltrials.gov) - Sep 28, 2022
P=N/A, N=21, Not yet recruiting, Sponsor: R-Bio
Trial completion date: Dec 2028 --> Dec 2029 | Trial primary completion date: Dec 2027 --> Dec 2028 Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Feb 2022 --> Aug 2024
- ||||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Enrollment closed, Enrollment change: Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial (clinicaltrials.gov) - Sep 28, 2022
P3, N=129, Active, not recruiting, Sponsor: R-Bio
Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Feb 2022 --> Aug 2024 Enrolling by invitation --> Active, not recruiting | N=260 --> 129
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial primary completion date, Head-to-Head: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis (clinicaltrials.gov) - Sep 23, 2022
P2b, N=140, Recruiting, Sponsor: Nature Cell Co. Ltd.
Enrolling by invitation --> Active, not recruiting | N=260 --> 129 Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Jun 2022 --> Jun 2023
- ||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Enrollment open, Trial primary completion date, Head-to-Head: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis (clinicaltrials.gov) - Jun 18, 2021
P2b, N=140, Recruiting, Sponsor: Nature Cell Co. Ltd.
Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Jun 2022 --> Jun 2023 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2021 --> Jun 2022
- ||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New trial: Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy (clinicaltrials.gov) - Apr 1, 2021
P=N/A, N=14, Not yet recruiting, Sponsor: R-Bio
- ||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New trial: Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration (clinicaltrials.gov) - Mar 28, 2021
P=N/A, N=21, Not yet recruiting, Sponsor: R-Bio
- ||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion, Trial primary completion date: Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients. (clinicaltrials.gov) - Jan 29, 2021
P=N/A, N=26, Completed, Sponsor: R-Bio
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2021 --> Jun 2022 Active, not recruiting --> Completed | Trial primary completion date: Feb 2020 --> May 2020
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion, Trial completion date, Trial primary completion date: Follow-up Study for Participants Jointstem Clinical Trial (clinicaltrials.gov) - Jan 29, 2021
P2b, N=11, Completed, Sponsor: R-Bio
Active, not recruiting --> Completed | Trial primary completion date: Feb 2020 --> May 2020 Active, not recruiting --> Completed | Trial completion date: Dec 2021 --> Dec 2020 | Trial primary completion date: Jun 2021 --> Dec 2020
- ||||||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion, Trial primary completion date: A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Jan 29, 2021
P3, N=260, Completed, Sponsor: R-Bio
Active, not recruiting --> Completed | Trial completion date: Dec 2021 --> Dec 2020 | Trial primary completion date: Jun 2021 --> Dec 2020 Active, not recruiting --> Completed | Trial primary completion date: Jun 2020 --> Dec 2020
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial initiation date, Head-to-Head: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis (clinicaltrials.gov) - Jan 18, 2021
P2b, N=140, Not yet recruiting, Sponsor: Nature Cell Co. Ltd.
Active, not recruiting --> Completed | Trial primary completion date: Jun 2020 --> Dec 2020 Initiation date: Dec 2020 --> Mar 2021
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial initiation date, Trial primary completion date, Head-to-Head: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis (clinicaltrials.gov) - Jun 23, 2020
P2b, N=140, Not yet recruiting, Sponsor: Nature Cell Co. Ltd.
Initiation date: Dec 2020 --> Mar 2021 Trial completion date: Jul 2022 --> Dec 2022 | Initiation date: Jun 2020 --> Dec 2020 | Trial primary completion date: Jun 2021 --> Dec 2021
- |||||||||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New P3 trial: Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial (clinicaltrials.gov) - Jun 11, 2020
P3, N=260, Enrolling by invitation, Sponsor: R-Bio
- ||||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Enrollment closed: A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - May 26, 2020
P3, N=260, Active, not recruiting, Sponsor: R-Bio
Trial completion date: Jul 2022 --> Dec 2022 | Initiation date: Jun 2020 --> Dec 2020 | Trial primary completion date: Jun 2021 --> Dec 2021 Recruiting --> Active, not recruiting
- ||||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New P2b trial, Head-to-Head: A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis (clinicaltrials.gov) - Apr 29, 2020
P2b, N=140, Not yet recruiting, Sponsor: Nature Cell Co. Ltd.
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion: A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Jan 2, 2020
P2, N=28, Completed, Sponsor: Nature Cell Co. Ltd.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New P3 trial: A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Jun 18, 2019
P3, N=260, Recruiting, Sponsor: R-Bio
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial primary completion date: Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients. (clinicaltrials.gov) - Jun 5, 2019
P=N/A, N=26, Active, not recruiting, Sponsor: Biostar
Active, not recruiting --> Completed Trial completion date: Mar 2019 --> Apr 2020 | Trial primary completion date: Dec 2018 --> Feb 2020
- | JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion date, Trial primary completion date: A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Aug 21, 2018
P2, N=28, Active, not recruiting, Sponsor: Nature Cell Co. Ltd.
Trial completion date: Mar 2019 --> Apr 2020 | Trial primary completion date: Dec 2018 --> Feb 2020 Trial completion date: Mar 2018 --> Mar 2019 | Trial primary completion date: Sep 2017 --> Mar 2018
- || JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Enrollment closed, Trial primary completion date: Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients. (clinicaltrials.gov) - Apr 26, 2018
P=N/A, N=26, Active, not recruiting, Sponsor: Biostar
Trial completion date: Mar 2018 --> Mar 2019 | Trial primary completion date: Sep 2017 --> Mar 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Dec 2018
- | JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Enrollment closed: A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Aug 29, 2017
P2, N=28, Active, not recruiting, Sponsor: Nature Cell Co. Ltd.
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> Dec 2018 Recruiting --> Active, not recruiting
- | JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Enrollment change: A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Jul 6, 2017
P2, N=30, Recruiting, Sponsor: Nature Cell Co. Ltd.
Recruiting --> Active, not recruiting N=45 --> 30
- JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New trial: Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients. (clinicaltrials.gov) - Dec 22, 2016
P=N/A, N=26, Recruiting, Sponsor: Biostar
- | JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion, Phase classification, Enrollment change: Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis (clinicaltrials.gov) - Dec 20, 2016
P2, N=24, Completed, Sponsor: Biostar
N=45 --> 30 Active, not recruiting --> Completed | Phase classification: P2/3 --> P2 | N=120 --> 24
- JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial primary completion date: A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Dec 6, 2016
P2, N=45, Recruiting, Sponsor: Nature Cell Co. Ltd.
Active, not recruiting --> Completed | Phase classification: P2/3 --> P2 | N=120 --> 24 Trial primary completion date: Mar 2017 --> Aug 2017
- JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New P2 trial: A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis (clinicaltrials.gov) - Feb 4, 2016
P2, N=45, Recruiting, Sponsor: Nature Cell Co. Ltd.
- |||||||||| JointStem (autologous adipose stem cell therapy) - K / STEMCELL
New P2/3 trial: Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis (clinicaltrials.gov) - Jan 19, 2016
P2/3, N=120, Active, not recruiting, Sponsor: Biostar
- | JointStem (autologous adipose stem cell therapy) - K / STEMCELL
Trial completion: Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis (clinicaltrials.gov) - May 23, 2012
P1/2, N=18, Completed, Sponsor: K-Stemcell Co Ltd
Trial primary completion date: Mar 2017 --> Aug 2017 Recruiting --> Completed